EFFECTS OF RENIN-ANGIOTENSIN SYSTEM BLOCKADE IN GUINEA-PIGS

被引:22
作者
VENIANT, M [1 ]
CLOZEL, JP [1 ]
HESS, P [1 ]
FISCHLI, W [1 ]
机构
[1] F HOFFMANN LA ROCHE & CO LTD, DIV PHARMA,PRECLIN RES, CH-4002 BASEL, SWITZERLAND
关键词
RENIN INHIBITORS; ANGIOTENSIN CONVERTING ENZYME INHIBITORS; ANGIOTENSIN-II; BLOOD PRESSURE; ANGIOTENSIN-I; GUINEA PIG STUDIES;
D O I
10.1161/01.HYP.19.3.255
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The goal of the present study was to compare the hemodynamic and biochemical effects of the renin inhibitor Ro 42-5892, the angiotensin converting enzyme inhibitor cilazapril, and the angiotensin II receptor blocker EXP132, the aldehyde derivative of DuP 753. The three drugs were evaluated in guinea pigs, previously treated with furosemide, using their maximal effective doses. Cilazapril decreased arterial blood pressure more than Ro 42-5892 and EXP132. In contrast, Ro 42-5892 and EXP132 had similar effects. The larger decrease of arterial pressure induced by cilazapril was not due to a larger decrease of angiotensin II in plasma and was not influenced by cyclooxygenase inhibition with indomethacin or by bradykinin antagonism with Hoe 140. After binephrectomy, most of the blood pressure-lowering effect of Ro 42-5892 disappeared. In contrast, cilazapril was still markedly effective, pointing to extrarenal effects. We conclude that in furosemide-treated guinea pigs, as opposed to previously published animal models, the decrease of arterial pressure induced by angiotensin converting enzyme inhibitors may be partly due to extrarenal effects not related to the renin-angiotensin system.
引用
收藏
页码:255 / 262
页数:8
相关论文
共 47 条
  • [1] METABOLISM AND PRODUCTION OF ANGIOTENSIN-I IN DIFFERENT VASCULAR BEDS IN SUBJECTS WITH HYPERTENSION
    ADMIRAAL, PJJ
    DERKX, FHM
    DANSER, AHJ
    PIETERMAN, H
    SCHALEKAMP, MADH
    [J]. HYPERTENSION, 1990, 15 (01) : 44 - 55
  • [2] COMPARISON OF RENIN AND CONVERTING ENZYME-INHIBITION IN SODIUM-DEFICIENT DOGS
    BLAINE, EH
    NELSON, BJ
    SEYMOUR, AA
    SCHORN, TW
    SWEET, CS
    SLATER, EE
    NUSSBERGER, J
    BOGER, J
    [J]. HYPERTENSION, 1985, 7 (03) : I66 - I71
  • [3] SPECIFIC-INHIBITION OF RENIN BY AN ANGIOTENSINOGEN ANALOG - STUDIES IN SODIUM DEPLETION AND RENIN-DEPENDENT HYPERTENSION
    BURTON, J
    CODY, RJ
    HERD, JA
    HABER, E
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (09): : 5476 - 5479
  • [4] CARINI DJ, 1987, Patent No. 253310
  • [5] CHANG RSL, 1990, MOL PHARMACOL, V37, P347
  • [6] Cinotti G A, 1983, J Hypertens Suppl, V1, P43
  • [7] IMMUNOREACTIVE RENIN, PRORENIN, AND ENZYMATICALLY ACTIVE RENIN IN PLASMA DURING PREGNANCY AND IN WOMEN TAKING ORAL-CONTRACEPTIVES
    DERKX, FHM
    STUENKEL, C
    SCHALEKAMP, MPA
    VISSER, W
    HUISVELD, IH
    SCHALEKAMP, MADH
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (04) : 1008 - 1015
  • [8] ANGIOTENSIN-I CONVERTING ENZYME
    ERDOS, EG
    [J]. CIRCULATION RESEARCH, 1975, 36 (02) : 247 - 255
  • [9] RO-42-5892 IS A POTENT ORALLY ACTIVE RENIN INHIBITOR IN PRIMATES
    FISCHLI, W
    CLOZEL, JP
    ELAMRANI, K
    WOSTL, W
    NEIDHART, W
    STADLER, H
    BRANCA, Q
    [J]. HYPERTENSION, 1991, 18 (01) : 22 - 31
  • [10] Fouad-Tarazi F M, 1988, Am J Med, V84, P83, DOI 10.1016/0002-9343(88)90209-4